You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced gastrointestinal tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Gastrointestinal Tumors Trial in Shanghai (Donafenib Tosilate Tablets, KN046 Injection)

Recruiting
  • Advanced Gastrointestinal Tumors
  • Donafenib Tosilate Tablets
  • KN046 Injection
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Nov 28, 2022

Adjuvant Treatment Trial (anlotinib+CAPEOX/SOX)

Not yet recruiting
  • Adjuvant Treatment
  • (no location specified)
Feb 15, 2023

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023

Advanced Solid Tumor Trial in Lianyungang (KT095 CAR-T injection)

Not yet recruiting
  • Advanced Solid Tumor
  • KT095 CAR-T injection
  • Lianyungang, Jiangsu, China
    Lianyungang First People's Hospital
Aug 23, 2022

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
  • long-acting Octreotide.
  • (no location specified)
May 22, 2023

Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Apatinib Mesylate
  • Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Mar 1, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)

Not yet recruiting
  • Gastrointestinal Tumors
  • AZD6422 CLDN18.2 CAR-T product
  • Beijing, China
    Beijing Cancer Hospital
Aug 1, 2023

Gastrointestinal Stromal Tumors, GIST Trial (Avapritinib, midazolam)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • GIST
  • (no location specified)
Jul 20, 2022

Gastroenteric Tumor Trial in Guangzhou (BL-M02D1)

Recruiting
  • Gastroenteric Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 31, 2022

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Gastrointestinal Stromal Tumors Trial in China (DCC-2618)

Completed
  • Gastrointestinal Stromal Tumors
  • Beijing, Beijing, China
  • +8 more
Aug 26, 2022

Gastrointestinal Stromal Tumors Trial in Toronto (BBI503)

Terminated
  • Gastrointestinal Stromal Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 4, 2022

Ripretinib Combined With Surgery in Advanced GIST That Have

Recruiting
  • Gastrointestinal Stromal Tumor(GIST)
  • Resection surgery of gastrointestinal stromal tumor
  • Chengdu, Sichuan, China
    Sichuan Provincial People's Hospital
Apr 25, 2022

Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Unifying Advanced Treatment With Advanced Imaging

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • Dual Energy CT
  • Mannheim, Germany
    University Center Mannheim
Apr 6, 2022

Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

Terminated
  • Gastrointestinal Cancer
  • +8 more
  • Serious Illness Conversation Guide (SICG)
  • Quality of Life (QOL) survey
  • Stanford, California
    Stanford Cancer Center
Jan 25, 2023

Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic

Recruiting
  • Unresectable Gastrointestinal Stromal Tumor (GIST)
  • +2 more
  • Atezolizumab 1200 mg
  • Imatinib 400 MG
  • Lyon, Rhône, France
  • +4 more
Apr 28, 2022

Gastrointestinal Stromal Tumors Trial in Japan, United States (DS-6157a)

Completed
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +4 more
Apr 7, 2022

Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Temozolomide capsule
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 14, 2022

Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid

Recruiting
  • Advanced or Late Stage Gastrointestinal Cancer
  • EV-array detection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 11, 2022

Ripretinib in Chinese Advanced GIST: a Real World Study

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • Ripretinib Oral Tablet
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 15, 2023

Second-line Pharmacotherapy Patterns and Outcomes of Advanced

Not yet recruiting
  • Gastrointestinal Stromal Tumors
    • Guangzhou, Guangdong, China
      The first affiliated hospital,Sun yat-sen university
    Jun 30, 2022